(Q44136927)
Statements
Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders (English)
Lôo H
Daléry J
Macher JP